Article

Recalibrating Patent Protection for COVID-19 Vaccines: A Path to Affordable Access and Equitable Distribution

2021-06-04

Abstract excerpt

A safe and effective COVID-19 vaccine is the holy grail of our generation, necessary to resurrect our societies, save millions of lives, and protect our economies from collapse. Patent protection is the primary legal mechanism for ensuring timely development of such a vaccine. The patent system is designed to create the necessary incentives for private parties to invest in developing the vaccine, knowing they will...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9d32d66d-3dce-5640-b1bd-a8dc01a15d48
DOI: 10.2139/ssrn.3855033

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Recalibrating Patent Protection for COVID-19 Vaccines: A Path to Affordable Access and Equitable DistributionDOI 10.2139/ssrn.3855033Read

The Intellectual Property of COVID-19Semantic proximity Read

Addressing Exclusivity Issues During the COVID-19 Pandemic and BeyondSemantic proximity Read

Promoting Vaccine InnovationSemantic proximity Read

Compelling Trade Secret TransfersSemantic proximity Read

Beyond Traditional IP: Addressing Regulatory BarriersSemantic proximity Read

§ 1498: A Guide to Government Patent Use, a Path to Licensing and Distributing Generic DrugsSemantic proximity Read

COVID-19 Trade Secrets and Information Access: An OverviewSemantic proximity Read

The Role of Intellectual Property Rights on Access to Medicines in the WHO African Region: 25 Years After the TRIPS AgreementSemantic proximity Read

Pathogen Genomes as Global Public Goods (And Why They Should not Be Patented)Semantic proximity Read

Strategic Use of Patent Opposition Safeguard to Improve Equitable Access to Innovative Health Technologies: A Case Study of CAR T-Cell Therapy KymriahSemantic proximity Read

Pathogen Genomes as Global Public Goods (and Why They Should Not Be Patented)Semantic proximity Read

Innovation Institutions and COVID-19, Part IISemantic proximity Read